Autoantibodies targeting glomerular annexin A2 identify patients with proliferative lupus nephritis

Proteomics - Clinical Applications

Volumn 9, Issue 11-12, 2015, Pages 1012-1020

  Caster, Dawn J ^a,b   Korte, Erik A ^a   Merchant, Michael L ^a   Klein, Jon B ^a,b   Wilkey, Daniel W ^a   Rovin, Brad H ^c   Birmingham, Dan J ^c   Harley, John B ^d,e   Cobb, Beth L ^d   Namjou, Bahram ^d   Mcleish, Kenneth R ^a,b   Powell, David W ^a  

^a University of Louisville School of Medicine   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d UNIVERSITY OF CINCINNATI   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Autoantibodies; Glomerulonephritis; Lupus nephritis; Systemic lupus erythematosus; Target antigens

Indexed keywords

AUTOANTIBODY; CALCIUM ION; LIPOCORTIN 2;

ANTIGEN ANTIBODY REACTION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LIQUID CHROMATOGRAPHY; LUPUS ERYTHEMATOSUS NEPHRITIS; MASS SPECTROMETRY; PODOCYTE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEOMICS; BLOOD; GLOMERULUS; IMMUNOLOGY; METABOLISM; PATHOLOGY;

ANNEXIN A2; AUTOANTIBODIES; HUMANS; KIDNEY GLOMERULUS; LUPUS NEPHRITIS;

EID: 84946601561     PISSN: 18628346     EISSN: 18628354     Source Type: Journal    
DOI: 10.1002/prca.201400175     Document Type: Article

References (63)

1. Tsokos, G. C., Systemic lupus erythematosus. N. Engl. J. Med. 2011, 365, 2110-2121.
2. Cozzani, E., Drosera, M., Gasparini, G., Parodi, A., Serology of Lupus erythematosus: correlation between immunopathological features and clinical aspects. Autoimmune Dis. 2014, 2014, 321359.
3. Bhinder, S., Singh, A., Majithia, V., Membranous (class V) renal disease in systemic lupus erythematosus may be more common than previously reported: results of a 6-year retrospective analysis. Am. J. Med. Sci. 2010, 339, 230-232.
4. Weening, J. J., D'Agati, V. D., Schwartz, M. M., Seshan, S. V. et al., The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int. 2004, 65, 521-530.
5. Mannik, M., Merrill, C. E., Stamps, L. D., Wener, M. H., Multiple autoantibodies form the glomerular immune deposits in patients with systemic lupus erythematosus. J. Rheumatol. 2003, 30, 1495-1504.
6. Seret, G., Le Meur, Y., Renaudineau, Y., Youinou, P., Mesangial cell-specific antibodies are central to the pathogenesis of lupus nephritis. Clin. Dev. Immunol. 2012, 2012, 579670.
7. Hanrotel-Saliou, C., Segalen, I., LeMeur, Y., Youinou, P., Renaudineau, Y., Glomerular antibodies in lupus nephritis. Clin. Rev. Allergy Immunol. 2011, 40, 151-158.
8. Olson, S. W., Lee, J. J., Prince, L. K., Baker, T. P. et al., Elevated subclinical double-stranded DNA antibodies and future proliferative lupus nephritis. Clin. J. Am. Soc. Nephrol. 2013, 8, 1702-1708.
9. Kalaaji, M., Mortensen, E., Jorgensen, L., Olsen, R., Rekvig, O. P., Nephritogenic lupus antibodies recognize glomerular basement membrane-associated chromatin fragments released from apoptotic intraglomerular cells. Am. J. Pathol. 2006, 168, 1779-1792.
10. Birmingham, D. J., Hebert, L. A., Song, H., Noonan, W. T. et al., Evidence that abnormally large seasonal declines in vitamin D status may trigger SLE flare in non-African Americans. Lupus 2012, 21, 855-864.
11. Rasmussen, A., Sevier, S., Kelly, J. A., Glenn, S. B. et al., The lupus family registry and repository. Rheumatology 2011, 50, 47-59.
12. Yamamoto, T., Renal and Urinary Proteomics, Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim 2009, pp. 1-7.
13. Saleem, M. A., O'Hare, M. J., Reiser, J., Coward, R. J. et al., A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression. J. Am. Soc. Nephrol. 2002, 13, 630-638.
14. Beck, L. H., Jr., Bonegio, R. G., Lambeau, G., Beck, D. M. et al., M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N. Engl. J. Med. 2009, 361, 11-21.
15. Powell, D. W., Rane, M. J., Joughin, B. A., Kalmukova, R. et al., Proteomic identification of 14-3-3zeta as a mitogen-activated protein kinase-activated protein kinase 2 substrate: role in dimer formation and ligand binding. Mol. Cell. Biol. 2003, 23, 5376-5387.
16. Cummins, T. D., Barati, M. T., Coventry, S. C., Salyer, S. A. et al., Quantitative mass spectrometry of diabetic kidney tubules identifies GRAP as a novel regulator of TGF-beta signaling. Biochim. Biophys. Acta 2010, 1804, 653-661.
17. Baba, S. P., Hoetker, J. D., Merchant, M., Klein, J. B. et al., Role of aldose reductase in the metabolism and detoxification of carnosine-acrolein conjugates. J. Biol. Chem. 2013, 288, 28163-28179.
18. Keller, A., Nesvizhskii, A. I., Kolker, E., Aebersold, R., Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal. Chem. 2002, 74, 5383-5392.
19. Nesvizhskii, A. I., Keller, A., Kolker, E., Aebersold, R., A statistical model for identifying proteins by tandem mass spectrometry. Anal. Chem. 2003, 75, 4646-4658.
20. Ashburner, M., Ball, C. A., Blake, J. A., Botstein, D. et al., Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet. 2000, 25, 25-29.
21. Seiler, C. Y., Park, J. G., Sharma, A., Hunter, P. et al., DNASU plasmid and PSI: biology-materials repositories: resources to accelerate biological research. Nucleic Acids Res. 2014, 42, D1253-D1260.
22. Delville, M., Sigdel, T. K., Wei, C., Li, J. et al., A circulating antibody panel for pretransplant prediction of FSGS recurrence after kidney transplantation. Sci. Transl. Med. 2014, 6, 256ra136.
23. Lefranc, D., Launay, D., Dubucquoi, S., de Seze, J. et al., Characterization of discriminant human brain antigenic targets in neuropsychiatric systemic lupus erythematosus using an immunoproteomic approach. Arthritis Rheum. 2007, 56, 3420-3432.
24. Reiser, J., Kriz, W., Kretzler, M., Mundel, P., The glomerular slit diaphragm is a modified adherens junction. J. Am. Soc. Nephrol. 2000, 11, 1-8.
25. Perysinaki, G. S., Moysiadis, D. K., Bertsias, G., Giannopoulou, I. et al., Podocyte main slit diaphragm proteins, nephrin and podocin, are affected at early stages of lupus nephritis and correlate with disease histology. Lupus 2011, 20, 781-791.
26. Welsh, G. I., Saleem, M. A., The podocyte cytoskeleton-key to a functioning glomerulus in health and disease. Nat. Rev. Nephrol. 2012, 8, 14-21.
27. Greka, A., Mundel, P., Calcium regulates podocyte actin dynamics. Seminars Nephrol. 2012, 32, 319-326.
28. Gee, H. Y., Saisawat, P., Ashraf, S., Hurd, T. W. et al., ARHGDIA mutations cause nephrotic syndrome via defective RHO GTPase signaling. J. Clin. Invest. 2013, 123, 3243-3253.
29. Meyer-Schwesinger, C., Dehde, S., Sachs, M., Mathey, S. et al., Rho-kinase inhibition prevents proteinuria in immune-complex-mediated antipodocyte nephritis. Am. J. Physiol. Renal. Physiol. 2012, 303, F1015-F1025.
30. Bharadwaj, A., Bydoun, M., Holloway, R., Waisman, D., Annexin A2 heterotetramer: structure and function. Int. J. Mol. Sci. 2013, 14, 6259-6305.
31. Yung, S., Cheung, K. F., Zhang, Q., Chan, T. M., Anti-dsDNA antibodies bind to mesangial annexin II in lupus nephritis. J. Am. Soc. Nephrol. 2010, 21, 1912-1927.
32. Pierchala, B. A., Munoz, M. R., Tsui, C. C., Proteomic analysis of the slit diaphragm complex: CLIC5 is a protein critical for podocyte morphology and function. Kidney Int. 2010, 78, 868-882.
33. Markoff, A., Gerke, V., Expression and functions of annexins in the kidney. Am. J. Physiol. Renal. Physiol. 2005, 289, F949-F956.
34. Rescher, U., Ludwig, C., Konietzko, V., Kharitonenkov, A., Gerke, V., Tyrosine phosphorylation of annexin A2 regulates Rho-mediated actin rearrangement and cell adhesion. J. Cell Sci. 2008, 121, 2177-2185.
35. Canas, F., Simonin, L., Couturaud, F., Renaudineau, Y., Annexin A2 autoantibodies in thrombosis and autoimmune diseases. Thrombosis Res. 2015, 135, 226-230.
36. Martin, M., Leffler, J., Blom, A. M., Annexin A2 and A5 serve as new ligands for C1q on apoptotic cells. J. Biol. Chem. 2012, 287, 33733-33744.
37. Leffler, J., Bengtsson, A. A., Blom, A. M., The complement system in systemic lupus erythematosus: an update. Ann. Rheum. Dis. 2014, 73, 1601-1606.
38. Diaz-Ramos, A., Roig-Borrellas, A., Garcia-Melero, A., Lopez-Alemany, R., alpha-Enolase, a multifunctional protein: its role on pathophysiological situations. J. Biomed. Biotechnol. 2012, 2012, 156795.
39. Bruschi, M., Sinico, R. A., Moroni, G., Pratesi, F. et al., Glomerular autoimmune multicomponents of human lupus nephritis In Vivo: alpha-Enolase and Annexin AI. J. Am. Soc. Nephrol. 2014, 25, 2483-2498.
40. Bruschi, M., Carnevali, M. L., Murtas, C., Candiano, G. et al., Direct characterization of target podocyte antigens and auto-antibodies in human membranous glomerulonephritis: alfa-enolase and borderline antigens. J. Proteomics 2011, 74, 2008-2017.
41. Hsu, H. H., Hoffmann, S., Endlich, N., Velic, A. et al., Mechanisms of angiotensin II signaling on cytoskeleton of podocytes. J. Mol. Med. 2008, 86, 1379-1394.
42. Hugo, C., Hugo, C., Pichler, R., Gordon, K. et al., The cytoskeletal linking proteins, moesin and radixin, are upregulated by platelet-derived growth factor, but not basic fibroblast growth factor in experimental mesangial proliferative glomerulonephritis. J. Clin. Invest. 1996, 97, 2499-2508.
43. Suzuki, K., Nagao, T., Itabashi, M., Hamano, Y. et al., A novel autoantibody against moesin in the serum of patients with MPO-ANCA-associated vasculitis. Nephrol. Dial. Transpl. 2014, 29, 1168-1177.
44. Doyle, A., Crosby, S. R., Burton, D. R., Lilley, F., Murphy, M. F., Actin bundling and polymerisation properties of eukaryotic elongation factor 1 alpha (eEF1A), histone H2A-H2B and lysozyme in vitro. J. Struct. Biol. 2011, 176, 370-378.
45. Wiege, K., Le, D. D., Syed, S. N., Ali, S. R. et al., Defective macrophage migration in Galphai2- but not Galphai3-deficient mice. J. Immunol. 2012, 189, 980-987.
46. Zhou, C. J., Lo, W. K., Association of clathrin, AP-2 adaptor and actin cytoskeleton with developing interlocking membrane domains of lens fibre cells. Exp. Eye Res. 2003, 77, 423-432.
47. Zanin-Zhorov, A., Nussbaum, G., Franitza, S., Cohen, I. R., Lider, O., T cells respond to heat shock protein 60 via TLR2: activation of adhesion and inhibition of chemokine receptors. FASEB J. 2003, 17, 1567-1569.
48. Lang, A., Benke, D., Eitner, F., Engel, D. et al., Heat shock protein 60 is released in immune-mediated glomerulonephritis and aggravates disease: in vivo evidence for an immunologic danger signal. J. Am. Soc. Nephrol. 2005, 16, 383-391.
49. Hurst, I. R., Zuo, J., Jiang, J., Holliday, L. S., Actin-related protein 2/3 complex is required for actin ring formation. J. Bone Min. Res. 2004, 19, 499-506.
50. Akiyama, K., Morita, H., Suetsugu, S., Kuraba, S. et al., Actin-related protein 3 (Arp3) is mutated in proteinuric BUF/Mna rats. Mamm. Genome 2008, 19, 41-50.
51. Lu, Y., Liu, X., Shi, S., Su, H. et al., Bioinformatics analysis of proteomic profiles during the process of anti-Thy1 nephritis. Mol. Cell. Proteomics 2012, 11, M111 008755.
52. Lin, C. P., Adrianto, I., Lessard, C. J., Kelly, J. A. et al., Role of MYH9 and APOL1 in African and non-African populations with lupus nephritis. Genes Immunity 2012, 13, 232-238.
53. Chen, H. H., Yu, H. I., Chiang, W. C., Lin, Y. D. et al., hnRNP Q regulates Cdc42-mediated neuronal morphogenesis. Mol. Cell. Biol. 2012, 32, 2224-2238.
54. Kremer, B. E., Adang, L. A., Macara, I. G., Septins regulate actin organization and cell-cycle arrest through nuclear accumulation of NCK mediated by SOCS7. Cell 2007, 130, 837-850.
55. Rosentreter, A., Hofmann, A., Xavier, C. P., Stumpf, M. et al., Coronin 3 involvement in F-actin-dependent processes at the cell cortex. Exp. Cell Res. 2007, 313, 878-895.
56. Liang, P., MacRae, T. H., Molecular chaperones and the cytoskeleton. J. Cell Sci. 1997, 110 (Pt 13), 1431-1440.
57. Khunkeawla, P., Moonsom, S., Staffler, G., Kongtawelert, P., Kasinrerk, W., Engagement of CD147 molecule-induced cell aggregation through the activation of protein kinases and reorganization of the cytoskeleton. Immunobiology 2001, 203, 659-669.
58. Kosugi, T., Maeda, K., Sato, W., Maruyama, S., Kadomatsu, K., CD147 (EMMPRIN/Basigin) in kidney diseases: from an inflammation and immune system viewpoint. Nephrol. Dial. Transpl. 2014.
59. Wasik, A. A., Koskelainen, S., Hyvonen, M. E., Musante, L. et al., Ezrin is down-regulated in diabetic kidney glomeruli and regulates actin reorganization and glucose uptake via GLUT1 in cultured podocytes. Am. J. Pathol. 2014, 184, 1727-1739.
60. Ostalska-Nowicka, D., Zachwieja, J., Nowicki, M., Kaczmarek, E. et al., Ezrin-a useful factor in the prognosis of nephrotic syndrome in children: an immunohistochemical approach. J. Clin. Pathol. 2006, 59, 916-920.
61. Ahn, Y. H., Gibbons, D. L., Chakravarti, D., Creighton, C. J. et al., ZEB1 drives prometastatic actin cytoskeletal remodeling by downregulating miR-34a expression. J. Clin. Invest. 2012, 122, 3170-3183.
62. Schmieder, S., Nagai, M., Orlando, R. A., Takeda, T., Farquhar, M. G., Podocalyxin activates RhoA and induces actin reorganization through NHERF1 and Ezrin in MDCK cells. J. Am. Soc. Nephrol. 2004, 15, 2289-2298.
63. Zha, D., Chen, C., Liang, W., Chen, X. et al., Nephrin phosphorylation regulates podocyte adhesion through the PINCH-1-ILK-alpha-parvin complex. BMB Rep. 2013, 46, 230-235.